South Korea
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
24.61%
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
2 |
8.11%
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
3 |
6.47%
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
4 |
6.04%
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
5 |
5.12%
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
6 |
4.41%
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
7 |
0.18%
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
8 |
-1.64%
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
9 |
-2.63%
|
Dec. 31, 2023 | USD 9.61 | -3.70% |
|
South Korea |
|
10 |
-3.49%
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
11 |
-20.01%
|
Dec. 31, 2023 | USD 8.83 | 4.03% |
|
South Korea |
|
12 |
-101.15%
|
Dec. 31, 2023 | USD 3.75 | -3.31% |
|
South Korea |
|
13 |
-111.94%
|
Dec. 31, 2023 | USD 10.77 | -3.15% |
|
South Korea |
|
14 |
-193.44%
|
Dec. 31, 2023 | USD 1.42 | -2.25% |
|
South Korea |
|
15 |
-241.69%
|
Dec. 31, 2023 | USD 4.40 | -2.27% |
|
South Korea |
|
16 |
-517.04%
|
Dec. 31, 2023 | USD 1.65 | -4.10% |
|
South Korea |
|
17 |
-740.68%
|
Dec. 31, 2023 | USD 1.23 | -3.88% |
|
South Korea |
|
18 |
-1,002.81%
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
|
19 |
-1,510.71%
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
The Vaccines company in South Korea with the highest Net Income Margin is Celltrion, Inc. (KSE: 068270.KS) at 24.61%.
The Vaccines company in South Korea with the lowest Net Income Margin is Genexine, Inc. (KOSDAQ: 095700.KQ) at -1,510.71%.
The top 10 Vaccines companies in South Korea by Net Income Margin are Celltrion, Inc., Daewoong pharmaceutical Co.,Ltd, Samjin Pharmaceuticals Co., Ltd., SK bioscience Co.,Ltd., Dong-A Socio Holdings Co., Ltd., Medy-Tox Inc., Seegene, Inc., Green Cross Corporation, Green Cross Holdings Corporation and ALTEOGEN Inc..
The bottom 10 Vaccines companies in South Korea by Net Income Margin are Genexine, Inc., CrystalGenomics, Inc., Gencurix Inc., SillaJen, Inc., Sugentech Inc., GeneOne Life Science, Inc., OliX Pharmaceuticals,Inc, iNtRON Biotechnology, Inc., EuBiologics Co., Ltd. and ALTEOGEN Inc..